These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 39060912)
1. Combination of PARP Inhibitors and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer. Kostos L; Tran B; Azad AA Drugs; 2024 Sep; 84(9):1093-1109. PubMed ID: 39060912 [TBL] [Abstract][Full Text] [Related]
2. Recent and Future Developments in the Use of Poly (ADP-ribose) Polymerase Inhibitors for Prostate Cancer. Zacchi F; Abida W; Antonarakis ES; Bryce AH; Castro E; Cheng HH; Shandhu S; Mateo J Eur Urol Oncol; 2024 Dec; ():. PubMed ID: 39638687 [TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of first-line systemic treatments for metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis. Ai J; Jian L; Wen X; Huo X; Yang X; Jiang J; Zhang T Clin Transl Oncol; 2024 Oct; 26(10):2559-2571. PubMed ID: 38750344 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Combination AKT and Androgen Receptor Signaling Inhibition in Metastatic Castration-Resistant Prostate Cancer: Systematic Review and Meta-Analysis. Nahar TAK; Bantounou MA; Savin I; Chohan N; Kumar NS; Ghose A; McEwan IJ Clin Genitourin Cancer; 2024 Dec; 22(6):102244. PubMed ID: 39549658 [TBL] [Abstract][Full Text] [Related]
5. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling. Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689 [TBL] [Abstract][Full Text] [Related]
6. Medication Prescription Policy for US Veterans With Metastatic Castration-Resistant Prostate Cancer: Causal Machine Learning Approach. Gopukumar D; Menon N; Schoen MW JMIR Med Inform; 2024 Nov; 12():e59480. PubMed ID: 39561358 [TBL] [Abstract][Full Text] [Related]
7. Bortezomib in multiple myeloma and lymphoma: a systematic review and clinical practice guideline. Reece D; Imrie K; Stevens A; Smith CA; Curr Oncol; 2006 Oct; 13(5):160-72. PubMed ID: 22792013 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
9. Far Posterior Approach for Rib Fracture Fixation: Surgical Technique and Tips. Manes TJ; DeGenova DT; Taylor BC; Patel JN JBJS Essent Surg Tech; 2024; 14(4):. PubMed ID: 39650795 [TBL] [Abstract][Full Text] [Related]
10. Circulating Biomarkers Predictive of Treatment Response in Patients with Hormone-sensitive or Castration-resistant Metastatic Prostate Cancer: A Systematic Review. Baboudjian M; Peyrottes A; Dariane C; Fromont G; Denis JA; Fiard G; Kassab D; Ladoire S; Lehmann-Che J; Ploussard G; Rouprêt M; Barthélémy P; Roubaud G; Lamy PJ Eur Urol Oncol; 2024 Dec; 7(6):1228-1245. PubMed ID: 38824003 [TBL] [Abstract][Full Text] [Related]
11. Impact of homologous recombination repair/BReast CAncer (BRCA) gene alterations on survival in a real-world setting of metastatic prostate cancer. Wenzel M; Hoeh B; Koll F; Humke C; Fassl A; Reis H; Wild P; Steuber T; Graefen M; Tilki D; Traumann M; Banek S; Chun FKH; Mandel P BJU Int; 2025 Jan; 135(1):117-124. PubMed ID: 38982928 [TBL] [Abstract][Full Text] [Related]
12. The effectiveness of school-based family asthma educational programs on the quality of life and number of asthma exacerbations of children aged five to 18 years diagnosed with asthma: a systematic review protocol. Walter H; Sadeque-Iqbal F; Ulysse R; Castillo D; Fitzpatrick A; Singleton J JBI Database System Rev Implement Rep; 2015 Oct; 13(10):69-81. PubMed ID: 26571284 [TBL] [Abstract][Full Text] [Related]
13. Intensification Approaches and Treatment Sequencing in Metastatic Castration-resistant Prostate Cancer: A Systematic Review. Francini E; Agarwal N; Castro E; Cheng HH; Chi KN; Clarke N; Mateo J; Rathkopf D; Saad F; Tombal B Eur Urol; 2025 Jan; 87(1):29-46. PubMed ID: 39306478 [TBL] [Abstract][Full Text] [Related]
14. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related]
16. Should Only Patients with BRCA Mutation Be Treated with a Combination of an Androgen Receptor Pathway Inhibitor and a PARP Inhibitor for Metastatic Castration-resistant Prostate Cancer? The Answer Is No. Saad F Eur Urol Focus; 2024 Jul; 10(4):506-508. PubMed ID: 39155209 [TBL] [Abstract][Full Text] [Related]
17. Interventions to reduce harm from continued tobacco use. Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465 [TBL] [Abstract][Full Text] [Related]